| Osteoarthritis: new insights. Part 1: the disease and its risk factors DT Felson, RC Lawrence, PA Dieppe, R Hirsch, CG Helmick, JM Jordan, ... Annals of internal medicine 133 (8), 635-646, 2000 | 3799 | 2000 |
| Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis DO Clegg, DJ Reda, CL Harris, MA Klein, JR O'Dell, MM Hooper, ... New England Journal of Medicine 354 (8), 795-808, 2006 | 2145 | 2006 |
| Epidemiology, etiology, and diagnosis of osteoporosis NE Lane American journal of obstetrics and gynecology 194 (2), S3-S11, 2006 | 1633 | 2006 |
| Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis KG Saag, R Emkey, TJ Schnitzer, JP Brown, F Hawkins, S Goemaere, ... New England Journal of Medicine 339 (5), 292-299, 1998 | 1601 | 1998 |
| 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid‐induced osteoporosis L Buckley, G Guyatt, HA Fink, M Cannon, J Grossman, KE Hansen, ... Arthritis & rheumatology 69 (8), 1521-1537, 2017 | 883 | 2017 |
| Tanezumab for the treatment of pain from osteoarthritis of the knee NE Lane, TJ Schnitzer, CA Birbara, M Mokhtarani, DL Shelton, MD Smith, ... New England Journal of Medicine 363 (16), 1521-1531, 2010 | 752 | 2010 |
| The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group ES Siris, R Adler, J Bilezikian, M Bolognese, B Dawson-Hughes, ... Osteoporosis international 25, 1439-1443, 2014 | 723 | 2014 |
| Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double‐blind, placebo‐controlled extension trial JD Adachi, KG Saag, PD Delmas, UA Liberman, RD Emkey, E Seeman, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 722 | 2001 |
| Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve‐month, multicenter, randomized, double‐blind … SB Cohen, RK Dore, NE Lane, PA Ory, CG Peterfy, JT Sharp, ... Arthritis & Rheumatism 58 (5), 1299-1309, 2008 | 678 | 2008 |
| Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. NE Lane, S Sanchez, GW Modin, HK Genant, E Pierini, CD Arnaud The Journal of clinical investigation 102 (8), 1627-1633, 1998 | 674 | 1998 |
| Osteoarthritis: MR imaging findings in different stages of disease and correlation with clinical findings TM Link, LS Steinbach, S Ghosh, M Ries, Y Lu, N Lane, S Majumdar Radiology 226 (2), 373-381, 2003 | 641 | 2003 |
| Thiazolidinedione use and bone loss in older diabetic adults AV Schwartz, DE Sellmeyer, E Vittinghoff, L Palermo, B Lecka-Czernik, ... The Journal of Clinical Endocrinology & Metabolism 91 (9), 3349-3354, 2006 | 638 | 2006 |
| Athletics and osteoarthritis JA Buckwalter, NE Lane The American journal of sports medicine 25 (6), 873-881, 1997 | 587 | 1997 |
| Long-distance running, bone density, and osteoarthritis NE Lane, DA Bloch, HH Jones, WH Marshall, PD Wood, JF Fries Jama 255 (9), 1147-1151, 1986 | 547 | 1986 |
| OARSI-FDA initiative: defining the disease state of osteoarthritis NE Lane, K Brandt, G Hawker, E Peeva, E Schreyer, W Tsuji, ... Osteoarthritis and cartilage 19 (5), 478-482, 2011 | 526 | 2011 |
| Radiographic osteoarthritis of the hip and bone mineral density MC Nevitt, NE Lane, JC Scott, MC Hochberg, AR Pressman, HK Genant, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1995 | 508 | 1995 |
| Classification of osteoarthritis biomarkers: a proposed approach DC Bauer, DJ Hunter, SB Abramson, M Attur, M Corr, D Felson, ... Osteoarthritis and Cartilage 14 (8), 723-727, 2006 | 504 | 2006 |
| Mechanical and biochemical changes in the superficial zone of articular cartilage in canine experimental osteoarthritis F Guilak, A Ratcliffe, N Lane, MP Rosenwasser, VC Mow Journal of Orthopaedic Research 12 (4), 474-484, 1994 | 472 | 1994 |
| Synovial inflammation in osteoarthritis progression E Sanchez-Lopez, R Coras, A Torres, NE Lane, M Guma Nature Reviews Rheumatology 18 (5), 258-275, 2022 | 426 | 2022 |
| The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial AD Sawitzke, H Shi, MF Finco, DD Dunlop, CO Bingham III, CL Harris, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 415 | 2008 |
